WeChat
Weibo
Channel
Scientific Research and Innovation
Technical Barrier
Fiman Biotechnology has obtained more than 40 utility model patents and 9 invention patents related to collagen, including the PET photo-controlled telopeptide removal technology, the CollaSUS emulsification technology and the SL15DP purification system. These patents involve key technologies of collagen production such as separation, purification, filtration, homogenization and emulsification, ensuring that the product has a complete triple helix structure, high biological activity and low immunogenicity.
Invention Patent
Over the past 20 years, the company has been deeply engaged in the basic research of collagen, focusing on the production process innovation and clinical application of collagen, and has obtained 9 national invention patents and more than 40 utility model patents, thus building a complete independent intellectual property system.
Scientific Research
With the cooperation with Sichuan University, Shaanxi University of Science and Technology, Fudan University and other universities and clinical experts, the whole chain of "basic research-clinical application-industrial transformation" has been opened up, and clinical research of existing products has been actively carried out to broaden the application scenarios. 10 articles have been published in medical journals at home and abroad, contributing to the development of the industry norms.
- Basic Research
- Clinical Application
- Complication Management
Traceability Management
In order to ensure the safety and quality of natural collagen raw materials and traceability, Fiman Biotechnology has invested in the construction of a medical cattle production base in Nehe of Heilongjiang Province, following strict feeding standards and inspection and testing processes. Each SIM-12 calf undergoes a series of tests, including BSE testing, to ensure that the best quality and stable collagen raw materials are provided.
